OPM provides examples of freestanding, home-based and physician office-based infusion centers offering savings compared to outpatient hospital departments
(1993) see ref
Damak, S., Mosinger, B
All are manufacturered by Novo Nordisk, who lead the way with their "wonder" diabetes and weight loss medications, starting with Victoza & Saxenda ( a daily injection ) before progressing to weekly injections ( Ozempic/Wegovy ) and a daily tablet ( Rybelsus )
Importantly, treatment discontinuation was considerably higher with semaglutide compared to placebo, which may affect long-term adherence, tolerability, and ultimately the effectiveness of semaglutide in practice
It resulted in acne, palpitations, anxiety, uncontrollable movements, facial redness, headache, and insomnia